Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 463637

Clinically relevant infusion rates of mu-opioid agonist remifentanil cause bradypnea in decerebrate dogs but not via direct effects in the pre-Bötzinger complex region


Mustapić, Sanda; Radočaj, Tomislav; Sanchez, A.; Đogaš, Zoran; Stucke, A.G.; Hopp, F.A.; Stuth, E.A.; Zuperku, E.J.
Clinically relevant infusion rates of mu-opioid agonist remifentanil cause bradypnea in decerebrate dogs but not via direct effects in the pre-Bötzinger complex region // Journal of neurophysiology, 103 (2010), 1; 409-418 doi:10.1152/jn.00188.2009 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 463637 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Clinically relevant infusion rates of mu-opioid agonist remifentanil cause bradypnea in decerebrate dogs but not via direct effects in the pre-Bötzinger complex region

Autori
Mustapić, Sanda ; Radočaj, Tomislav ; Sanchez, A. ; Đogaš, Zoran ; Stucke, A.G. ; Hopp, F.A. ; Stuth, E.A. ; Zuperku, E.J.

Izvornik
Journal of neurophysiology (0022-3077) 103 (2010), 1; 409-418

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
remifentanil; dogs; pre-Bötzinger complex

Sažetak
Systemic administration of mu-opioids at clinical doses for analgesia typically slows respiratory rate. Mu-opioid receptors (MORs) on pre-Bötzinger Complex (pre-BötC) respiratory neurons, the putative kernel of respiratory rhythmogenesis, are potential targets. The purpose of this study was to determine the contribution of pre-BötC MORs to the bradypnea produced in vivo by intravenous administration of clinically relevant infusion rates of remifentanil (remi), a short-acting, potent mu-opioid analgesic. In decerebrate dogs, multibarrel micropipettes were used to record pre-BötC neuronal activity and to eject the opioid antagonist naloxone (NAL, 0.5 mM), the glutamate agonist D-homocysteic acid (DLH, 20 mM), or the MOR agonist [D-Ala(2), N-Me-Phe(4), gly-ol(5)]-enkephalin (DAMGO, 100 microM). Inspiratory and expiratory durations (T(I) and T(E)) and peak phrenic nerve activity (PPA) were measured from the phrenic neurogram. The pre-BötC was functionally identified by its rate altering response (typically tachypnea) to DLH microinjection. During intravenous remi-induced bradypnea (approximately 60% decrease in central breathing frequency, f(B)), bilateral injections of NAL in the pre-BötC did not change T(I), T(E), f(B), and PPA. Also, NAL picoejected onto single pre-BötC neurons depressed by intravenous remi had no effect on their discharge. In contrast, approximately 60 microg/kg of intravenous NAL rapidly reversed all remi-induced effects. In a separate group of dogs, microinjections of DAMGO in the pre-BötC increased f(B) by 44%, while subsequent intravenous remi infusion more than offset this DAMGO induced tachypnea. These results indicate that mu-opioids at plasma concentrations that cause profound analgesia produce their bradypneic effect via MORs located outside the pre-BötC region.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
216-2163166-0513 - Neuralna kontrola disanja u budnosti i spavanju (Đogaš, Zoran, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url Tomislav Radočaj (autor)

Avatar Url Zoran Đogaš (autor)

Poveznice na cjeloviti tekst rada:

doi jn.physiology.org jn.physiology.org

Citiraj ovu publikaciju:

Mustapić, Sanda; Radočaj, Tomislav; Sanchez, A.; Đogaš, Zoran; Stucke, A.G.; Hopp, F.A.; Stuth, E.A.; Zuperku, E.J.
Clinically relevant infusion rates of mu-opioid agonist remifentanil cause bradypnea in decerebrate dogs but not via direct effects in the pre-Bötzinger complex region // Journal of neurophysiology, 103 (2010), 1; 409-418 doi:10.1152/jn.00188.2009 (međunarodna recenzija, članak, znanstveni)
Mustapić, S., Radočaj, T., Sanchez, A., Đogaš, Z., Stucke, A., Hopp, F., Stuth, E. & Zuperku, E. (2010) Clinically relevant infusion rates of mu-opioid agonist remifentanil cause bradypnea in decerebrate dogs but not via direct effects in the pre-Bötzinger complex region. Journal of neurophysiology, 103 (1), 409-418 doi:10.1152/jn.00188.2009.
@article{article, author = {Mustapi\'{c}, Sanda and Rado\v{c}aj, Tomislav and Sanchez, A. and \DJoga\v{s}, Zoran and Stucke, A.G. and Hopp, F.A. and Stuth, E.A. and Zuperku, E.J.}, year = {2010}, pages = {409-418}, DOI = {10.1152/jn.00188.2009}, keywords = {remifentanil, dogs, pre-B\"{o}tzinger complex}, journal = {Journal of neurophysiology}, doi = {10.1152/jn.00188.2009}, volume = {103}, number = {1}, issn = {0022-3077}, title = {Clinically relevant infusion rates of mu-opioid agonist remifentanil cause bradypnea in decerebrate dogs but not via direct effects in the pre-B\"{o}tzinger complex region}, keyword = {remifentanil, dogs, pre-B\"{o}tzinger complex} }
@article{article, author = {Mustapi\'{c}, Sanda and Rado\v{c}aj, Tomislav and Sanchez, A. and \DJoga\v{s}, Zoran and Stucke, A.G. and Hopp, F.A. and Stuth, E.A. and Zuperku, E.J.}, year = {2010}, pages = {409-418}, DOI = {10.1152/jn.00188.2009}, keywords = {remifentanil, dogs, pre-B\"{o}tzinger complex}, journal = {Journal of neurophysiology}, doi = {10.1152/jn.00188.2009}, volume = {103}, number = {1}, issn = {0022-3077}, title = {Clinically relevant infusion rates of mu-opioid agonist remifentanil cause bradypnea in decerebrate dogs but not via direct effects in the pre-B\"{o}tzinger complex region}, keyword = {remifentanil, dogs, pre-B\"{o}tzinger complex} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font